← Leaderboards
Liuqing Yang
University Of Tx Md Anderson Can Ctr
$6,260,577
Attributed
$8,624,171
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,624,171 · 7
By mechanism
R01$7,799,993 · 5
R00$683,926 · 1
K99$140,252 · 1
Top collaborators
- Jianjun Gao3 shared
- Vernon R Sutton3 shared
- Wenbo Li2 shared
- Pavlos Msaouel2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Pavlos Msaouel$1,797,255
- Jianjun Gao$3,992,332
- Xiaodong Cheng$20,199,960
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingMolecularMouse ModelTumor GrowthMalignant NeoplasmsSignal TransductionPhosphorylationGenetic TranscriptionResistancePre-ClinicalInnovationPlayNeoplasm MetastasisAnimal ModelSuccessMutantEffectivenessResponseTargeted TreatmentTreatment StrategyTyrosineIn VivoPatient-Focused OutcomesProteins
Grant awards (21)
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation$671,046
R01 · FY2025 · CA · contact PI
Molecular Mechanisms of Bladder Cancer Immunometabolism$493,870
R01 · FY2025 · CA · contact PI
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria$472,897
R01 · FY2025 · HD · contact PI
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation$686,919
R01 · FY2024 · CA · contact PI
Molecular Mechanisms of Bladder Cancer Immunometabolism$468,881
R01 · FY2024 · CA · contact PI
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria$468,169
R01 · FY2024 · HD · contact PI
Molecular Mechanisms of Bladder Cancer Immunometabolism$508,855
R01 · FY2023 · CA · contact PI
Molecular Mechanism of long Noncoding RNAs in Phenylketonuria$503,897
R01 · FY2023 · HD · contact PI
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer$425,403
R01 · FY2021 · CA · contact PI
Combinatorial Treatment Strategies to Counteract EGFR Resistance$364,016
R01 · FY2021 · CA · contact PI
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer$425,403
R01 · FY2020 · CA · contact PI
Combinatorial Treatment Strategies to Counteract EGFR Resistance$364,016
R01 · FY2020 · CA · contact PI
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer$412,640
R01 · FY2019 · CA · contact PI
Combinatorial Treatment Strategies to Counteract EGFR Resistance$353,095
R01 · FY2019 · CA · contact PI
Rational Combination Therapy with PARP Inhibitors in Triple Negative Breast Cancer$425,403
R01 · FY2018 · CA · contact PI
Combinatorial Treatment Strategies to Counteract EGFR Resistance$366,935
R01 · FY2018 · CA · contact PI
Combinatorial Treatment Strategies to Counteract EGFR Resistance$388,548
R01 · FY2017 · CA · contact PI
Mechanistic Roles of Long mcRNA-regulated Gene Transcription in Prostate Cancer$223,877
R00 · FY2015 · CA · contact PI
Mechanistic Roles of Long mcRNA-regulated Gene Transcription in Prostate Cancer$225,990
R00 · FY2014 · CA · contact PI
Mechanistic Roles of Long mcRNA-regulated Gene Transcription in Prostate Cancer$234,059
R00 · FY2013 · CA · contact PI
Role of ncRNA-mediated Relocation of AR Transcription Units in Prostate Cancer$140,252
K99 · FY2012 · CA · contact PI